Quantcast
Channel: メディカルプレスセンター QLifePro »医学
Browsing all 5442 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Takeda Showcases Broadened Oncology Portfolio Through Data Presentations at...

  CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature new clinical analyses and outcomes research during three upcoming...

View Article


Image may be NSFW.
Clik here to view.

ドンペが中等度および重度の成人神経栄養性角膜炎患者の治療薬としてのOxervate®(Cenegermin点眼薬)に対するCHMPの肯定的意見を欧州で受領

  ミラノ (ビジネスワイヤ) —...

View Article


Image may be NSFW.
Clik here to view.

SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven...

  FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, has announced that the MSB Strategic Planning Committee has selected Dr. Shigeru Terabe, Professor Emeritus of the...

View Article

Image may be NSFW.
Clik here to view.

Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见

  米兰 (美国商业资讯) — 生物制药公司Dompé今天宣布,EMA(欧洲药品署)人用药品委员会(CHMP)发布了一项肯定意见,建议签发Oxervate®(cenegermin...

View Article

Image may be NSFW.
Clik here to view.

EpimAb Biotherapeutics Collaborates with WuXi Biologics to Advance Lead...

  SHANGHAI EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, and WuXi Biologics, a WuXi AppTec Affiliate, announced today a...

View Article


Image may be NSFW.
Clik here to view.

岸迈生物携手药明生物推进创新双抗药物进入临床开发

  中国,上海 今天,岸迈生物科技有限公司(EpimAb Biotherapeutics)宣布与药明康德关联公司药明生物达成战略合作协议,共同推进岸迈生物的第一个创新双抗药物EMB-01于2018年进入新药临床申报。...

View Article

Image may be NSFW.
Clik here to view.

Ortho-ACI® Included on the Australian Register of Therapeutic Goods

  PERTH, Australia Regenerative medicine company Orthocell Limited (“Orthocell or Company”) is pleased to announce it has received confirmation from the Therapeutic Goods Administration (TGA) that...

View Article

Image may be NSFW.
Clik here to view.

武田在即将召开的医学会议上呈报数据,展示其强大的肿瘤产品阵容

  马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE:...

View Article


Image may be NSFW.
Clik here to view.

Dr Michael S. Perry Appointed Avita Medical CEO

  VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH; OTCQX: AVMXY) has appointed Dr Michael (Mike)...

View Article


Image may be NSFW.
Clik here to view.

世界首创基于基因组的共享型经济平台‘MGB(mygenomebox),’ 利用DNA App在CES Asia 2017运营全新生活体验区

  首尔 (美国商业资讯)– 基于基因组的共享型经济平台MGB(mygenomebox)参展“CES Asia 2017”敲响了其进入亚洲市场的钟声。 今年的CES ASIA在中国上海新国际博览中心(SNIEC)召开,展期从6月7日起到9日,将展出包括美国、中国在内的世界最大市场及亚洲各国最新家电产品市场走向和产品。 MGB曾于今年1月参加在拉斯维加斯举办的世界国际电子产品博览会(Consumer...

View Article

Image may be NSFW.
Clik here to view.

SpaceOAR®システムが日本で承認を取得

  米マサチューセッツ州ベッドフォード (ビジネスワイヤ) ­­ 放射線療法において放射線のリスクから臓器を離し保護するための専有技術である吸収性ハイドロゲルを開発・製造・販売する医療技術企業のAugmenix,...

View Article

Image may be NSFW.
Clik here to view.

Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA...

  CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the randomized...

View Article

Image may be NSFW.
Clik here to view.

FDA核准Claret Medical的Sentinel脑保护系统在美国上市

  加州圣罗莎 (美国商业资讯) — Claret...

View Article


Image may be NSFW.
Clik here to view.

クラレット・メディカルが米国でセンティネル脳保護システムを販売するためのFDA承認を取得

  米カリフォルニア州サンタローザ (ビジネスワイヤ) —...

View Article

Image may be NSFW.
Clik here to view.

Astellas and Pfizer Announce Amendment to Clinical Research Protocol for...

  TOKYO & NEW YORK Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE:PFE) announced today the amendment of the protocol for the...

View Article


Image may be NSFW.
Clik here to view.

口服IDHIFA® (enasidenib) 1期试验的更新数据显示IDH2突变的复发或难治AML患者的完全缓解率和缓解持续时间

  芝加哥 (美国商业资讯) — Celgene Corporation (NASDAQ:CELG)与Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)今天发布了进行中的1期剂量递增和扩展研究的有效性及安全性新数据,该研究评估口服研究药物IDHIFA® (enasidenib)用于异柠檬酸脱氢酶-2 (IDH2)突变的复发或难治急性粒细胞性白血病(R/R...

View Article

Image may be NSFW.
Clik here to view.

Exelixis Announces Initiation of Phase 1b Trial of Cabozantinib in...

  SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ:EXEL) today announced the initiation of the dose-escalation stage of a phase 1b trial of cabozantinib in combination with atezolizumab (TECENTRIQ®)...

View Article


Image may be NSFW.
Clik here to view.

Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates...

  SAN BRUNO, Calif. Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a...

View Article

Image may be NSFW.
Clik here to view.

武田薬品、拡大したオンコロジーポートフォリオを近日開催の医学学会におけるデータ発表を通じて紹介

  米マサチューセッツ州ケンブリッジ & 大阪 (ビジネスワイヤ) — 武田薬品工業株式会社(TSE:...

View Article

Image may be NSFW.
Clik here to view.

IDHIFA®(enasidenib)経口薬の第1相試験から得た最新データは、IDH2変異を持つ再発性/難治性AML患者における完全奏功率および奏功期間を示す

  シカゴ (ビジネスワイヤ) — セルジーン・コーポレーション(NASDAQ:CELG)とアジオス・ファーマシューティカルズ(NASDAQ:AGIO)は本日、進行中の第1相用量漸増/拡大試験から得た有効性/安全性データを発表しました。本試験は、イソクエン酸デヒドロゲナーゼ2(IDH2)変異持つ再発性/難治性急性骨髄性白血病(R/R...

View Article
Browsing all 5442 articles
Browse latest View live